Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs

Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs

  • July 30, 2026

Attovia Therapeutics, Braveheart Bio and Vogenx have set target ranges for their IPOs, positioning the trio to collectively net more than $500 million from public investors.

Leave A Comment

Fields (*) Mark are Required